Ganglioside GM3 Participates in the Pathological Conditions of Insulin Resistance
Open accessThe DOI matches its Crossref record; 60 of the 62 references it cites were found in a registry or an index.
Abstract
Gangliosides are known as modulators of transmembrane signaling by regulating various receptor functions. We have found that insulin resistance induced by tumor necrosis factor-alpha (TNF-alpha) in 3T3-L1 adipocytes was accompanied by increased GM3 ganglioside expression caused by elevating GM3 synthase activity and its mRNA. We also demonstrated that TNF-alpha simultaneously produced insulin resistance by uncoupling insulin receptor activity toward insulin receptor substrate-1 (IRS-1) and suppressing insulin-sensitive glucose transport. Pharmacological depletion of GM3 in adipocytes by an inhibitor of glucosylceramide synthase prevented the TNF-alpha-induced defect in insulin-dependent tyrosine phosphorylation of IRS-1 and also counteracted the TNF-alpha-induced serine phosphorylation of IRS-1. Moreover, when the adipocytes were incubated with exogenous GM3, suppression of tyrosine phosphorylation of insulin receptor and IRS-1 and glucose uptake in response to insulin stimulation was observed, demonstrating that GM3 itself is able to mimic the effects of TNF on insulin signaling. We used the obese Zucker fa/fa rat and ob/ob mouse, which are known to overproduce TNF-alpha mRNA in adipose tissues, as typical models of insulin resistance. We found that the levels of GM3 synthase mRNA in adipose tissues of these animals were significantly higher than in their lean counterparts. Taken together, the increased synthesis of cellular GM3 by TNF may participate in the pathological conditions of insulin resistance in type 2 diabetes.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“and elimination of GM3 affects insulin receptor action (405, 523 -524).”
From Biological roles of glycans (2017) · cites this paper as [523]
Citations
Cites
Adipose Expression of Tumor Necrosis Factor-α: Direct Role in Obesity-Linked Insulin Resistance
Hotamisligil, G. S., Shargill, N. S., & Spiegelman, B. M. (1993) · Science · doi:10.1126/science.7678183 · Cited by 7,518
Heid, C. A., Stevens, J., Livak, K. J., & Williams, P. M. (1996) · Genome Research · doi:10.1101/gr.6.10.986 · Cited by 6,174
Hotamisligil, G. S., Arner, P., Caro, J. F., Atkinson, R. L., & Spiegelman, B. M. (1995) · Journal of Clinical Investigation · doi:10.1172/jci117936 · Cited by 3,543
Hotamisligil, G. S., Peraldi, P., Budavari, A., Ellis, R., White, M. F., & Spiegelman, B. M. (1996) · Science · doi:10.1126/science.271.5249.665 · Cited by 2,630
Protection from obesity-induced insulin resistance in mice lacking TNF-α function
Uysal, K. T., Wiesbrock, S. M., Marino, M. W., & Hotamisligil, G. S. (1997) · Nature · doi:10.1038/39335 · Cited by 2,234
Aguirre, V., Uchida, T., Yenush, L., Davis, R., & White, M. F. (2000) · Journal of Biological Chemistry · doi:10.1074/jbc.275.12.9047 · Cited by 1,487
Boyle, W. J., van der Geer, P., & Hunter, T. (1991) · Methods in Enzymology · doi:10.1016/0076-6879(91)01013-r · Cited by 1,434
Tumor Necrosis Factor α: A Key Component of the Obesity-Diabetes Link
Hotamisligil, G. S., & Spiegelman, B. M. (1994) · Diabetes · doi:10.2337/diab.43.11.1271 · Cited by 1,281
Tumor necrosis factor alpha inhibits signaling from the insulin receptor.
Hotamisligil, G. S., Murray, D. L., Choy, L. N., & Spiegelman, B. M. (1994) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.91.11.4854 · Cited by 1,199
Insulin Resistance — Mechanisms, Syndromes, and Implications
Epstein, F. H., Moller, D. E., & Flier, J. S. (1991) · New England Journal of Medicine · doi:10.1056/nejm199109263251307 · Cited by 801
Research works printed but not linked: 4
- Moller, 1992, N. Engl. J. Med., 325, 938
- Radin, 1993, Adv. Lipid Res., 26, 183
- Tanaka, 1994, 76, 374
- Engelman, 2000, Mol. Endocrinol., 14, 1557
Cited by
Varki, A. (2017) · Glycobiology · doi:10.1093/glycob/cww086 · Cited by 2,635
“the EGF receptor (517–522) and elimination of GM3 affects insulin receptor action (405, 523, 524).”
BackgroundAutophagy and signaling: their role in cell survival and cell death
Codogno, P., & Meijer, A. J. (2005) · Cell Death & Differentiation · doi:10.1038/sj.cdd.4401751 · Cited by 1,092
“sphingolipid pathway has been implicated in the etiology of insulin resistance.(64) Interestingly, ceramide has been shown to activate autophagy by upregulating beclin1 and inhibiting PKB;(65) a decrease in intracellular amino-acid concentrations and a decrease in mTOR-dependent signaling may also have contributed to…”
BackgroundCeramides in insulin resistance and lipotoxicity
SUMMERS, S. (2006) · Progress in Lipid Research · doi:10.1016/j.plipres.2005.11.002 · Cited by 848
Cawthorn, W. P., & Sethi, J. K. (2008) · FEBS Letters · doi:10.1016/j.febslet.2007.11.051 · Cited by 791
“alter IR tyrosine kinase signal transduction [99] (Fig.”
BackgroundCeramides – Lipotoxic Inducers of Metabolic Disorders
Chaurasia, B., & Summers, S. A. (2015) · Trends in Endocrinology & Metabolism · doi:10.1016/j.tem.2015.07.006 · Cited by 616
“Of relevance to the discussion herein, GM3 (monosialodihexosylganglioside) disrupts interactions between insulin and its receptor in adipocytes [70].”
BackgroundA Ceramide-Centric View of Insulin Resistance
Chavez, J. A., & Summers, S. A. (2012) · Cell Metabolism · doi:10.1016/j.cmet.2012.04.002 · Cited by 610
Holland, W. L., & Summers, S. A. (2008) · Endocrine Reviews · doi:10.1210/er.2007-0025 · Cited by 595
“Exogenous GM3 gangliosides inhibit insulin receptor tyrosine phosphorylation and IRS-1 tyrosine phosphorylation in cultured 3T3-L1 adipocytes.”
BackgroundInfluentialLysosomal disorders: From storage to cellular damage
Ballabio, A., & Gieselmann, V. (2009) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/j.bbamcr.2008.12.001 · Cited by 571
“In contrast, increased G M3 ganglio-side levels impair insulin receptor signalling [22].”
Sethi, J. K., & Vidal-Puig, A. J. (2007) · Journal of Lipid Research · doi:10.1194/jlr.r700005-jlr200 · Cited by 563
“Although some evidence already exists implicating GM3 in altering receptor tyrosine kinase signal transduction (27, 28), future lipidomic investigations should help elucidate the identities and mechanisms by which specific glycosphingolipid(s) mediate insulin resistance.”
Enhanced insulin sensitivity in mice lacking ganglioside GM3
Yamashita, T., Hashiramoto, A., Haluzik, M., Mizukami, H., Beck, S., Norton, A., Kono, M., Tsuji, S., Daniotti, J. L., Werth, N., et al. (2003) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0635898100 · Cited by 531
Gene expression in human NAFLD
Greco, D., Kotronen, A., Westerbacka, J., Puig, O., Arkkila, P., Kiviluoto, T., Laitinen, S., Kolak, M., Fisher, R. M., Hamsten, A., et al. (2008) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.00074.2008 · Cited by 427
“Glycosphingolipids have the ability to suppress phosphorylation of the insulin receptor (54).”
BackgroundSphingolipids and phospholipids in insulin resistance and related metabolic disorders
Meikle, P. J., & Summers, S. A. (2017) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2016.169 · Cited by 423
Ceramides as modulators of cellular and whole-body metabolism
Bikman, B. T., & Summers, S. A. (2011) · Journal of Clinical Investigation · doi:10.1172/jci57144 · Cited by 419
Kabayama, K., Sato, T., Saito, K., Loberto, N., Prinetti, A., Sonnino, S., Kinjo, M., Igarashi, Y., & Inokuchi, J.-I. (2007) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0703650104 · Cited by 388
Self-citationThe metabolism and function of sphingolipids and glycosphingolipids
Lahiri, S., & Futerman, A. H. (2007) · Cellular and Molecular Life Sciences · doi:10.1007/s00018-007-7076-0 · Cited by 344
Wang, R., Li, B., Lam, S. M., & Shui, G. (2020) · Journal of Genetics and Genomics · doi:10.1016/j.jgg.2019.11.009 · Cited by 330
Combinatorial Ganglioside Biosynthesis
Kolter, T., Proia, R. L., & Sandhoff, K. (2002) · Journal of Biological Chemistry · doi:10.1074/jbc.r200001200 · Cited by 322
Pharmacological Inhibition of Glucosylceramide Synthase Enhances Insulin Sensitivity
Aerts, J. M., Ottenhoff, R., Powlson, A. S., Grefhorst, A., van Eijk, M., Dubbelhuis, P. F., Aten, J., Kuipers, F., Serlie, M. J., Wennekes, T., et al. (2007) · Diabetes · doi:10.2337/db06-1619 · Cited by 301
“Inokuchi and colleagues (15) used the ceramide analog 1-phenyl-2decanoylamino-3-morpholinopropanol (PDMP), an inhibitor of glucosylceramide synthase, to reduce glycosphingolipids in cultured adipocytes.”
InfluentialGlycosphingolipids: synthesis and functions
D'Angelo, G., Capasso, S., Sticco, L., & Russo, D. (2013) · FEBS Journal · doi:10.1111/febs.12559 · Cited by 298
Glycosphingolipids—Nature, Function, and Pharmacological Modulation
Wennekes, T., van den Berg, R. J. B. H. N., Boot, R. G., van der Marel, G. A., Overkleeft, H. S., & Aerts, J. M. F. G. (2009) · Angewandte Chemie International Edition · doi:10.1002/anie.200902620 · Cited by 288
Altered Adipose and Plasma Sphingolipid Metabolism in Obesity
Samad, F., Hester, K. D., Yang, G., Hannun, Y. A., & Bielawski, J. (2006) · Diabetes · doi:10.2337/db06-0330 · Cited by 279
“Our results showing that GM3 synthase is decreased in epididymal fat pads of ob/ob mice are in contrast to previous reports in which GM3 synthase mRNA was shown to be increased in adipose tissues of Zucker fa/fa rats and ob/ob mice (29).”
ResultEscribá, P. V., Busquets, X., Inokuchi, J.-I., Balogh, G., Török, Z., Horváth, I., Harwood, J. L., & Vígh, L. (2015) · Progress in Lipid Research · doi:10.1016/j.plipres.2015.04.003 · Cited by 252
“TNFa produces a striking increase in cellular ganglioside GM3 levels in mouse 3T3-L1 adipocytes in a state of insulin resistance, and in the adipose tissues of obese/diabetic rodents, including Zucker fa/fa rats and ob/ob mice [141].”
BackgroundSelf-citationSignalling and autophagy regulation in health, aging and disease
Meijer, A. J., & Codogno, P. (2006) · Molecular Aspects of Medicine · doi:10.1016/j.mam.2006.08.002 · Cited by 244
“Because palmitate is the precursor of ceramide and sphingolipid biosynthesis, the sphingolipid pathway has been implicated in the etiology of insulin resistance (Tagami et al., 2002; Yamashita et al., 2003).”
BackgroundZhao, H., Przybylska, M., Wu, I.-H., Zhang, J., Siegel, C., Komarnitsky, S., Yew, N. S., & Cheng, S. H. (2007) · Diabetes · doi:10.2337/db06-0719 · Cited by 238
Membrane Domains and the “Lipid Raft” Concept
Sonnino, S., & Prinetti, A. (2012) · Current Medicinal Chemistry · doi:10.2174/09298673130103 · Cited by 214
Randeria, P. S., Seeger, M. A., Wang, X.-Q., Wilson, H., Shipp, D., Mirkin, C. A., & Paller, A. S. (2015) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1505951112 · Cited by 224
Nanoparticle-Based Therapeutic Approach for Diabetic Wound Healing
Ezhilarasu, H., Vishalli, D., Dheen, S. T., Bay, B.-H., & Srinivasan, D. K. (2020) · Nanomaterials · doi:10.3390/nano10061234 · Cited by 210
“GM3S is key intermediary of insulin resistance which has proven to be highly expressed in human diabetic foot skin, diabetes stimulated obese mouse, hyperglycemic mouse, and mouse keratinocytes exposed to high glucose [96,97].”
BackgroundYoon, S.-J., Nakayama, K.-I., Hikita, T., Handa, K., & Hakomori, S.-I. (2006) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0609281103 · Cited by 210
Adipose Tissue Function and Expandability as Determinants of Lipotoxicity and the Metabolic Syndrome
Carobbio, S., Pellegrinelli, V., & Vidal-Puig, A. (2017) · Advances in Experimental Medicine and Biology · doi:10.1007/978-3-319-48382-5_7 · Cited by 194
Biosynthesis and degradation of mammalian glycosphingolipids
Sandhoff, K., & Kolter, T. (2003) · Philosophical Transactions of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rstb.2003.1265 · Cited by 183
Boccuto, L., Aoki, K., Flanagan-Steet, H., Chen, C.-F., Fan, X., Bartel, F., Petukh, M., Pittman, A., Saul, R., Chaubey, A., et al. (2014) · Human Molecular Genetics · doi:10.1093/hmg/ddt434 · Cited by 182
Natoli, T. A., Smith, L. A., Rogers, K. A., Wang, B., Komarnitsky, S., Budman, Y., Belenky, A., Bukanov, N. O., Dackowski, W. R., Husson, H., et al. (2010) · Nature Medicine · doi:10.1038/nm.2171 · Cited by 180
Park, J.-W., Park, W.-J., Kuperman, Y., Boura-Halfon, S., Pewzner-Jung, Y., & Futerman, A. H. (2013) · Hepatology · doi:10.1002/hep.26015 · Cited by 169
Lipid oversupply, selective insulin resistance, and lipotoxicity: Molecular mechanisms
Chavez, J. A., & Summers, S. A. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2009.09.015 · Cited by 169
The Role of Glycosphingolipids in Immune Cell Functions
Zhang, T., de Waard, A. A., Wuhrer, M., & Spaapen, R. M. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2019.00090 · Cited by 160
“Thus, upregulation of GM3, for example after TNF-α stimulation, results in insulin resistance (139, 159).”
BackgroundLipids and glycosphingolipids in caveolae and surrounding plasma membrane of primary rat adipocytes
Örtegren, U., Karlsson, M., Blazic, N., Blomqvist, M., Nyström, F. H., Gustavsson, J., Fredman, P., & Strålfors, P. (2004) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.2004.04117.x · Cited by 181
“GM3 has been implicated in causing insulin resistance in 3T3L1 adipocytes [53], and mutant mice lacking GM3 synthase, thus unable to synthesize GM3, were without major abnormalities but showed a heightened sensitivity to insulin [54].”
BackgroundKabayama, K. (2004) · Glycobiology · doi:10.1093/glycob/cwh135 · Cited by 155
Self-citationGlycosphingolipids and Neuroinflammation in Parkinson’s Disease
Belarbi, K., Cuvelier, E., Bonte, M.-A., Desplanque, M., Gressier, B., Devos, D., & Chartier-Harlin, M.-C. (2020) · Molecular Neurodegeneration · doi:10.1186/s13024-020-00408-1 · Cited by 155
Lubricating cell signaling pathways with gangliosides
Allende, M. L., & Proia, R. L. (2002) · Current Opinion in Structural Biology · doi:10.1016/s0959-440x(02)00376-7 · Cited by 163
Glycosphingolipid behaviour in complex membranes
Prinetti, A., Loberto, N., Chigorno, V., & Sonnino, S. (2008) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/j.bbamem.2008.09.001 · Cited by 152
Roles of ceramide and sphingolipids in pancreatic β-cell function and dysfunction
Boslem, E., Meikle, P. J., & Biden, T. J. (2012) · Islets · doi:10.4161/isl.20102 · Cited by 174
Regulation of Growth Factor Receptors by Gangliosides
Miljan, E. A., & Bremer, E. G. (2002) · Science's STKE · doi:10.1126/stke.2002.160.re15 · Cited by 150
Mediators of cytokine-induced insulin resistance in obesity and other inflammatory settings
Marette, A. (2002) · Current Opinion in Clinical Nutrition and Metabolic Care · doi:10.1097/00075197-200207000-00005 · Cited by 149
Ceramides and Glucosylceramides Are Independent Antagonists of Insulin Signaling
Chavez, J. A., Siddique, M. M., Wang, S. T., Ching, J., Shayman, J. A., & Summers, S. A. (2014) · Journal of Biological Chemistry · doi:10.1074/jbc.m113.522847 · Cited by 147
“An insulin-resistant adipocyte model was established as described previously with minor modifications (22).”
New insights on glucosylated lipids: Metabolism and functions
Ishibashi, Y., Kohyama‐Koganeya, A., & Hirabayashi, Y. (2013) · Biochimica et Biophysica Acta (BBA) - Molecular and Cell Biology of Lipids · doi:10.1016/j.bbalip.2013.06.001 · Cited by 166
“On the other hand, adipocytes are more sensitive to glucosylated sphingolipids [59,65].”
BackgroundLipid Mediators of Insulin Resistance
Holland, W. L., Knotts, T. A., Chavez, J. A., Wang, L.-P., Hoehn, K. L., & Summers, S. A. (2008) · Nutrition Reviews · doi:10.1111/j.1753-4887.2007.tb00327.x · Cited by 139
“For example, the use of a glucosylceramide synthase inhibitor prevented TNF-alpha-induced defects in insulin signaling.(35) Moreover, mice lacking GM3 synthase (CMP-NeuAc:lactosylceramide alpha2,3-sialyltransferase) demonstrated increased sensitivity to insulin, enhanced insulin receptor phosphorylation in skeletal mu…”
Lipid rafts: Keys to neurodegeneration
Schengrund, C. (2010) · Brain Research Bulletin · doi:10.1016/j.brainresbull.2010.02.013 · Cited by 154
Sphingolipids and insulin resistance: the five Ws
Summers, S. A. (2010) · Current Opinion in Lipidology · doi:10.1097/mol.0b013e3283373b66 · Cited by 136
Gangliosides Trigger Inflammatory Responses via TLR4 in Brain Glia
Jou, I., Lee, J. H., Park, S. Y., Yoon, H. J., Joe, E.-H., & Park, E. J. (2006) · American Journal Of Pathology · doi:10.2353/ajpath.2006.050924 · Cited by 150
Wennekes, T., van den Berg, R. J. B. H. N., Donker‐Koopman, W. E., van der Marel, G. A., Strijland, A., Aerts, J. M. F. G., & Overkleeft, H. S. (2007) · The Journal of Organic Chemistry · doi:10.1021/jo061280p · Cited by 154
Connecting Alzheimer's disease to diabetes: Underlying mechanisms and potential therapeutic targets
Vieira, M. N. N., Lima-Filho, R. A. S., & De Felice, F. G. (2018) · Neuropharmacology · doi:10.1016/j.neuropharm.2017.11.014 · Cited by 132
Sasaki, A., Hata, K., Suzuki, S., Sawada, M., Wada, T., Yamaguchi, K., Obinata, M., Tateno, H., Suzuki, H., & Miyagi, T. (2003) · Journal of Biological Chemistry · doi:10.1074/jbc.m212200200 · Cited by 126
Translational aspects of sphingolipid metabolism
Zeidan, Y. H., & Hannun, Y. A. (2007) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2007.06.002 · Cited by 150
Lingwood, C. A. (2011) · Cold Spring Harbor Perspectives in Biology · doi:10.1101/cshperspect.a004788 · Cited by 159
“Exogenous GM3 also reduced insulin dependent IRS-1phosphorylation (Tagami et al. 2002).”
BackgroundIkeda, K., Shimizu, T., & Taguchi, R. (2008) · Journal of Lipid Research · doi:10.1194/jlr.d800038-jlr200 · Cited by 124
How Do Gangliosides Regulate RTKs Signaling?
Julien, S., Bobowski, M., Steenackers, A., Bourhis, X. L., & Delannoy, P. (2013) · Cells · doi:10.3390/cells2040751 · Cited by 136
“Moreover, inhibition of ganglioside biosynthesis by PDMP, a specific inhibitor of the GlcCer synthase, restores insulin signaling, whereas addition of exogenous GM3 inhibits the IR substrate 1 (IRS-1) phosphorylation and IR signaling pathway [94,96].”
BackgroundGlycosphingolipids and insulin resistance
Langeveld, M., & Aerts, J. M. F. G. (2009) · Progress in Lipid Research · doi:10.1016/j.plipres.2009.03.002 · Cited by 133
“Tagami and coworkers later estab-lised that addition of GM3 to cultured adipocytes suppresses phosphorylation of IR and its down-stream substrate IRS-1, resulting in reduced glucose uptake 104 .”
Schnaar, R. L. (2018) · Advances in carbohydrate chemistry and biochemistry · doi:10.1016/bs.accb.2018.09.002 · Cited by 135
Zhao, Y., Miao, H., Cheng, X., & Wei, F. (2015) · Chemico-Biological Interactions · doi:10.1016/j.cbi.2015.09.005 · Cited by 127
“The interaction of ectopic GM3 with the insulin receptor has been demonstrated to directly participated in the biochemical mechanism of insulin resistance [129,130].”
BackgroundGlycolipids and Lectins in Endocytic Uptake Processes
Johannes, L., Wunder, C., & Shafaq‐Zadah, M. (2016) · Journal of Molecular Biology · doi:10.1016/j.jmb.2016.10.027 · Cited by 128
van Eijk, M., Aten, J., Bijl, N., Ottenhoff, R., van Roomen, C. P. A. A., Dubbelhuis, P. F., Seeman, I., Ghauharali-van der Vlugt, K., Overkleeft, H. S., Arbeeny, C., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0004723 · Cited by 112
“It has been demonstrated by us that inhibition of glucosylceramide synthase (GCS) activity with N-(5-adamantane-1-yl-methoxy)- pentyl-1-deoxynojirimycin (AMP-DNM) corrects insulin resistance in cultured adipocytes from obese individuals and 3T3 cells exposed to TNF-a [33].”
BackgroundBioorganic Chemistry of Ceramide
Brodesser, S., Sawatzki, P., & Kolter, T. (2003) · European Journal of Organic Chemistry · doi:10.1002/ejoc.200200518 · Cited by 107
Toledo, M. S., Suzuki, É., Handa, K., & Hakomori, S. (2005) · Journal of Biological Chemistry · doi:10.1074/jbc.m413713200 · Cited by 116
Diabetes Alters Sphingolipid Metabolism in the Retina
Fox, T. E., Han, X., Kelly, S. L., Merrill, A. H., Martin, R. E., Anderson, R. E., Gardner, T. W., & KESTER, M. A. (2006) · Diabetes · doi:10.2337/db06-0539 · Cited by 111
“Furthermore, glycosphingolipids have been demonstrated to activate microglial cell lines to produce the inflammatory mediators inducible nitric oxide synthase, TNF- , and IL-1 through protein kinase C and NADPH oxidase (58) and protein kinase A (59).”
BackgroundInfluentialGender, Contraceptives and Individual Metabolic Predisposition Shape a Healthy Plasma Lipidome
Sales, S., Graessler, J., Ciucci, S., Al-Atrib, R., Vihervaara, T., Schuhmann, K., Kauhanen, D., Sysi-Aho, M., Bornstein, S. R., Bickle, M., et al. (2016) · Scientific Reports · doi:10.1038/srep27710 · Cited by 103
Glucocerebrosidase: Functions in and Beyond the Lysosome
Boer, D. E. C., van Smeden, J., Bouwstra, J. A., & Aerts, J. M. F. G. (2020) · Journal of Clinical Medicine · doi:10.3390/jcm9030736 · Cited by 114
“Residing in the GSL-enriched domains are proteins involved in interactions of cells with the exterior (extracellular space and other cells) and mediating the associated intracellular signaling processes [24–26].”
BackgroundGender-Related Differences in the Metabolic Response to Fasting
Soeters, M. R., Sauerwein, H. P., Groener, J. E., Aerts, J. M., Ackermans, M. T., Glatz, J. F. C., Fliers, E., & Serlie, M. J. (2007) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-0552 · Cited by 103
The Nutritional Significance of Lipid Rafts
Yaqoob, P. (2009) · Annual Review of Nutrition · doi:10.1146/annurev-nutr-080508-141205 · Cited by 102
A view on sphingolipids and disease
Kolter, T. (2011) · Chemistry and Physics of Lipids · doi:10.1016/j.chemphyslip.2011.04.013 · Cited by 120
Sphingolipids: players in the pathology of metabolic disease
Cowart, L. A. (2008) · Trends in Endocrinology and Metabolism · doi:10.1016/j.tem.2008.09.004 · Cited by 114
Brozinick, J. T., Hawkins, E., Bui, H. H., Kuo, M.-S., Tan, B., Kievit, P., & Grove, K. L. (2012) · International Journal of Obesity · doi:10.1038/ijo.2012.191 · Cited by 118
Wennekes, T., Meijer, A. J., Groen, A. K., Boot, R. G., Groener, J. E. M., van Eijk, M., Ottenhoff, R., Bijl, N., der Vlugt, K. G., Song, H., et al. (2009) · Journal of Medicinal Chemistry · doi:10.1021/jm901281m · Cited by 107
Exogenous Ganglioside GD1a Enhances Epidermal Growth Factor Receptor Binding and Dimerization
Liu, Y., Li, R., & Ladisch, S. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.m402880200 · Cited by 102
Hirahara, Y., Bansal, R., Honke, K., Ikenaka, K., & Wada, Y. (2004) · Glia · doi:10.1002/glia.10327 · Cited by 96
“…by phase contrast (not shown), note that in the control only a few differentiated OL are seen, while in the Cst / mice cultures numerous mature OLs are already present with a corresponding increase in the MBP protein levels. mons and Toomre, 2000; Taylor et al., 2002; Baron et al., 2003).”
BackgroundInfluence of dietary gangliosides on neonatal brain development
McJarrow, P., Schnell, N., Jumpsen, J., & Clandinin, T. M. (2009) · Nutrition Reviews · doi:10.1111/j.1753-4887.2009.00211.x · Cited by 102
On ceramides, other sphingolipids and impaired glucose homeostasis
Larsen, P. J., & Tennagels, N. (2014) · Molecular Metabolism · doi:10.1016/j.molmet.2014.01.011 · Cited by 93
Glycosphingolipid–Protein Interaction in Signal Transduction
Russo, D., Parashuraman, S., & D’Angelo, G. (2016) · International Journal of Molecular Sciences · doi:10.3390/ijms17101732 · Cited by 102
“Notably, indeed, over the last decades, a number of studies have demonstrated how GSLs influence the behaviour and signalling capability of membrane proteins [2,19–29].”
BackgroundNovel Insights and Mechanisms of Lipotoxicity-Driven Insulin Resistance
Lair, B., Laurens, C., Bosch, B. V. D., & Moro, C. (2020) · International Journal of Molecular Sciences · doi:10.3390/ijms21176358 · Cited by 107
Haque, S. T., Saha, S. K., Haque, M. E., & Biswas, N. (2021) · Biomaterials Science · doi:10.1039/d1bm01211h · Cited by 92
Inhibiting glycosphingolipid synthesis ameliorates hepatic steatosis in obese mice #
Zhao, H., Przybylska, M., Wu, I.-H., Zhang, J., Maniatis, P., Pacheco, J., Piepenhagen, P., Copeland, D., Arbeeny, C., Shayman, J. A., et al. (2009) · Hepatology · doi:10.1002/hep.22970 · Cited by 88
Therapeutic applications of iminosugars: Current perspectives and future opportunities
Horne, G., & Wilson, F. X. (2011) · Progress in medicinal chemistry · doi:10.1016/b978-0-12-381290-2.00004-5 · Cited by 87
Sphingolipid Metabolism and Signaling in Skeletal Muscle: From Physiology to Physiopathology
Tan, S., Guitton, J., Bourron, O., Stunff, H. L., & Hajduch, É. (2020) · Frontiers in Endocrinology · doi:10.3389/fendo.2020.00491 · Cited by 94
“TNFαinduced insulin resistance was shown to be associated with high concentrations of GM3 in adipocytes (171), and GM3 synthase”
BackgroundSphingolipid metabolism in non-alcoholic fatty liver diseases
Régnier, M., Polizzi, A., Guillou, H., & Loiseau, N. (2018) · Biochimie · doi:10.1016/j.biochi.2018.07.021 · Cited by 95
Glycosphingolipids and mitochondria: Role in apoptosis and disease
Morales, A., Colell, A., Marí, M., García‐Ruiz, C., & Fernández-Checa, J. C. (2003) · Glycoconjugate Journal · doi:10.1023/b:glyc.0000043294.62504.2c · Cited by 86
Sphingolipids: agents provocateurs in the pathogenesis of insulin resistance
Lipina, C., & Hundal, H. S. (2011) · Diabetologia · doi:10.1007/s00125-011-2127-3 · Cited by 83
“is no supporting evidence in tissues obtained from obese or diabetic humans [88].”
BackgroundInfluentialRamirez, T., Longato, L., Dostalek, M., Tong, M., Wands, J. R., & de la Monte, S. M. (2013) · Alcohol and Alcoholism · doi:10.1093/alcalc/ags106 · Cited by 82
“In contrast, no significant inter-group differences or trends were observed with respect to IL-1α, IL-1β, IL-4, IL-5, IL-6, IL-12 p70, IL-17, Eotaxin, G-colony-stimulating factor (CSF), granulocyte-macrophage (GM)-CSF, macrophage-CSF, RANTES, tumor necrosis factor alpha (TNF-α) or vascular endothelial growth factor (V…”
BackgroundInfluentialType I Gaucher Disease, a Glycosphingolipid Storage Disorder, Is Associated with Insulin Resistance
Langeveld, M., Ghauharali, K. J. M., Sauerwein, H. P., Ackermans, M. T., Groener, J. E. M., Hollak, C. E. M., Aerts, J. M., & Serlie, M. J. (2008) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2007-1702 · Cited by 82
“Glycosphingolipid metabolism influences insulin sensitivity 6,13 .”
Ganglioside GM3 is involved in neuronal cell death
Sohn, H., Kim, Y.-S., Kim, H.-T., Kim, C., Cho, E., Kang, H., Kim, N.-S., Kim, C., Ryu, S. E., Lee, J. H., et al. (2006) · The FASEB Journal · doi:10.1096/fj.05-4911fje · Cited by 87
“An increase in GM3 levels is required for the induction of terminal differentiation, culminating in death by apoptosis, of human colonic carcinoma cells in vitro (35), as has been observed during cell death by metastasis-suppressing gene products (36), and induced by treatment with tumor necrosis factor- (TNF- ) (37).”
Backgroundder Vlugt, K. G., Langeveld, M., Poppema, A., Kuiper, S., Hollak, C. E. M., Aerts, J. M. F. G., & Groener, J. E. M. (2008) · Clinica Chimica Acta · doi:10.1016/j.cca.2007.12.001 · Cited by 85
“Recent reports implicate gangliosides like GM3 as important negative regulators of insulin sensitivity in liver and peripheral tissues 11–14 .”
The nutritional and clinical significance of lipid rafts
Yaqoob, P., & Shaikh, S. R. (2010) · Current Opinion in Clinical Nutrition & Metabolic Care · doi:10.1097/mco.0b013e328335725b · Cited by 76
Messner, M. C., & Cabot, M. C. (2010) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-6741-1_11 · Cited by 89
Lipid-mediated muscle insulin resistance: different fat, different pathways?
Ritter, O., Jelenik, T., & Roden, M. (2015) · Journal of Molecular Medicine · doi:10.1007/s00109-015-1310-2 · Cited by 74
“The synthesis of ganglioside monosialo 3 (GM3) is induced by TNF-α and paralleled by decreased tyrosine phosphorylation of the insulin receptor and IRS1 (IRS1-tyrPx), resulting in impaired insulin-stimulated glucose uptake in 3T3-L1 adipocytes [42].”
BackgroundLipidomics applications for disease biomarker discovery in mammal models
Zhao, Y., Cheng, X., Lin, R., & Wei, F. (2015) · Biomarkers in Medicine · doi:10.2217/bmm.14.81 · Cited by 75
Glycosphingolipids and lysosomal storage disorders as illustrated by gaucher disease
Aerts, J. M. F. G., Kuo, C. J., Lelieveld, L. T., Boer, D. E. C., van der Lienden, M. J. C., Overkleeft, H. S., & Artola, M. (2019) · Current Opinion in Chemical Biology · doi:10.1016/j.cbpa.2019.10.006 · Cited by 81
Jennemann, R., & Gröne, H. (2013) · Progress in Lipid Research · doi:10.1016/j.plipres.2013.02.001 · Cited by 74
Sphingolipids and membrane environments for caveolin
Sonnino, S., & Prinetti, A. (2009) · FEBS Letters · doi:10.1016/j.febslet.2009.01.007 · Cited by 87
“In 3T3-L1 adipocytes, the induction of insulin resistance by treatment with tumor necrosis factor alpha was accompanied by the upregulation of GM3 synthase, leading to an increase of cellular GM3 [91,94], that accumulated in detergentresistant membranes.”
BackgroundInokuchi, J., Inamori, K., Kabayama, K., Nagafuku, M., Uemura, S., Go, S., Suzuki, A., Ohno, I., Kanoh, H., & Shishido, F. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.10.004 · Cited by 72
Self-citationShui, G., Stebbins, J. W., Lam, B. D., Cheong, W. F., Lam, S. M., Gregoire, F., Kusonoki, J., & Wenk, M. R. (2011) · PLoS ONE · doi:10.1371/journal.pone.0019731 · Cited by 68
“This trend observed in diabetic monkeys was unexpected as GM3 has been reported as a negative regulator of insulin signaling [12,30,31].”
Backgroundβ-Glycosphingolipids improve glucose intolerance and hepatic steatosis of the Cohen diabetic rat
Zigmond, E., Zangen, S. W., Pappo, O., Sklair‐Levy, M., Lalazar, G., Zolotaryova, L., Raz, I., & Ilan, Y. (2008) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.90634.2008 · Cited by 71
“Since glycosphingolipids were shown to negatively modulate the activity of the insulin receptor (31), the use of Genz-123346, an inhibitor of glycosphinFig.”
MethodGangliosides in Membrane Organization
Sonnino, S., Chiricozzi, E., Grassi, S., Mauri, L., Prioni, S., & Prinetti, A. (2018) · Progress in molecular biology and translational science · doi:10.1016/bs.pmbts.2017.12.007 · Cited by 68
Metadata
- Authors
- Tagami, S., Inokuchi, J.-I., Kabayama, K., Yoshimura, H., Kitamura, F., Uemura, S., Ogawa, C., Ishii, A., Saito, M., Ohtsuka, Y., Sakaue, S., & Igarashi, Y.
- Affiliations
- Hokkaido University (JP)
- National Cancer Centre Japan (JP)
- Corresponding author
- Inokuchi, Jin-ichi
- ORCID
- Venue
- Journal of Biological Chemistry
- Publisher
- Elsevier BV
- Published
- 2002-02
- Volume
- 277
- Issue
- 5
- Pages
- 3085-3092
- ISSN
- 0021-9258 (ISSN-L)
- OpenAlex
- W2157934599
- Cited by
- 355
- References
- 62
- Citations by year
- 2026: 4 · 2025: 6 · 2024: 10 · 2023: 2 · 2022: 16 · 2021: 14 · 2020: 27 · 2019: 14 · 2018: 13 · 2017: 13 · 2016: 14 · 2015: 23 · 2014: 17 · 2013: 18 · 2012: 19
- FWCI
- 8.36
- Type
- journal article
- Language
- en
- Open access
- hybrid
- doi.org
- Licence
- cc-by
- www.elsevier.com/tdm/userlicense/1.0/ (tdm)
- creativecommons.org/licenses/by/4.0/ (vor, 6818 d)
- Locations
- Journal of Biological Chemistry (publishedVersion, cc-by)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Adipokines, Inflammation, and Metabolic Diseases
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Sphingolipid Metabolism and Signaling
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Lipid metabolism and biosynthesis
- Keywords
- GM3 ganglioside, insulin resistance, TNF-α, GM3 synthase, IRS-1, IRS-1 serine phosphorylation, insulin receptor tyrosine phosphorylation, glucose transport, adipocytes, type 2 diabetes, obesity, glucosylceramide synthase inhibition, 3T3-L1 adipocytes, Zucker fatty rats, ob/ob mice
- MeSH terms
- Animals, Cell Differentiation, Enzyme Inhibitors, G(M3) Ganglioside, Glucosyltransferases, Insulin, Insulin Resistance, Mice, Obese, Rats, Zucker, Sialyltransferases, Transcription, Genetic, Tumor Necrosis Factor-alpha, Signal Transduction, 3T3 Cells, Adipocytes, Mice, Rats
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.